Saturday, July 3, 2021

GSK agrees to support manufacture of Novavax’ COVID-19 vaccine




GlaxoSmithKline (GSK) has agreed in principle to support manufacturing of up to 60 million doses of Novavax’ COVID-19 vaccine candidate – NVX-CoV2373 – for use in the UK.

GSK has agreed with Novavax and the UK government Vaccines Taskforce to provide fill and finish manufacturing capacity at its Barnard Castle facility in the North East of England, starting as early as May 2021.

Fill and finish is the completion stage of vaccine manufacturing – during this stage, vials of the final vaccine are prepared and packaged for distribution and use.

According to GSK, the parties will negotiate a final agreement to include additional terms and conditions, although technology transfer between the two companies is set to begin ‘immediately’.

The protein antigen component of NVX-CoV2373 is produced by Novavax’ manufacturing partner FUJIFILM Diosynth Biotechnologies at its site in Billingham, Stockton-on-Tees.

“I’m delighted by GSK’s investment, which shows the strength of UK manufacturing, and will further boost our vaccine rollout,” said Prime Minister Boris Johnson.

“The Vaccines Taskforce has worked hand in glove with business to successfully deliver vaccines to the whole of the UK, and this agreement will continue to support our approach. We remain on track to offer a first jab to all over 50s by 15 April, and all adults by the end of July, and I want to once again encourage everyone to come forward for a vaccine when you’re called,” he added.

The UK government has signed an advance purchase agreement with Novavax for 60 million doses of NVX-CoV2373.



Source link

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...